• SPX
  • $5,959.27
  • 0.71 %
  • $42.16
  • DJI
  • $43,945.39
  • 1.24 %
  • $536.91
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $19,005.90
  • 0.21 %
  • $39.76
INVO Bioscience, Inc. (INVO) Stock Price, News & Analysis

INVO Bioscience, Inc. (INVO) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.82
Day's range
$0.88
50-day range
$0.6311
Day's range
$1.42
  • Country: US
  • ISIN: US44984F4019
52 wk range
$0.63
Day's range
$3.5
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -5.84
  • Piotroski Score 4.00
  • Grade Neutral
  • Symbol (INVO)
  • Company INVO Bioscience, Inc.
  • Price $0.83
  • Changes Percentage (-2%)
  • Change -$0.02
  • Day Low $0.82
  • Day High $0.88
  • Year High $3.50

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/10/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.45
  • Trailing P/E Ratio -0.54
  • Forward P/E Ratio -0.54
  • P/E Growth -0.54
  • Net Income $-8,034,612

Income Statement

Quarterly

Annual

Latest News of INVO

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

INVO Bioscience, Inc. Frequently Asked Questions

  • What is the INVO Bioscience, Inc. stock price today?

    Today's price of INVO Bioscience, Inc. is $0.83 — it has decreased by -2% in the past 24 hours. Watch INVO Bioscience, Inc. stock price performance more closely on the chart.

  • Does INVO Bioscience, Inc. release reports?

    Yes, you can track INVO Bioscience, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the INVO Bioscience, Inc. stock forecast?

    Watch the INVO Bioscience, Inc. chart and read a more detailed INVO Bioscience, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is INVO Bioscience, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by INVO Bioscience, Inc. stock ticker.

  • How to buy INVO Bioscience, Inc. stocks?

    Like other stocks, INVO shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is INVO Bioscience, Inc.'s EBITDA?

    INVO Bioscience, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in INVO Bioscience, Inc.’s financial statements.

  • What is the INVO Bioscience, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -2.6599611001, which equates to approximately -266.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in INVO Bioscience, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including INVO Bioscience, Inc.'s financials relevant news, and technical analysis. INVO Bioscience, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for INVO Bioscience, Inc. stock currently indicates a “sell” signal. For more insights, review INVO Bioscience, Inc.’s technical analysis.

  • A revenue figure for INVO Bioscience, Inc. for its last quarter?

    INVO Bioscience, Inc. published it's last quarterly revenues at $1.84 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.